Skip to main content
Caplight Logo









MOLEQLAR

MOLEQLAR

Private
BerlinConsumer & Commercehttps://moleqlar.com/

Last Round

Seed

Nov 9, 2023

Momentum

Top 5%

of companies Caplight tracks

Company Overview

MOLEQLAR is a biotechnology and food company that develops and distributes science-based longevity products including nutritional supplements and health tests.

Sector

Consumer & Commerce

Verticals

D2C Brands, Subscription Commerce, Precision Medicine, Biotechnology, E-commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium, Services & Consulting

AI Layer

Application

Keywords

longevitylongevity supplementsat-home health testsbiological age testbiohackingNAD testNMN supplementepigeneticspersonalized supplementspreventative healthspermidine supplementDTCsubscription commercecorporate healthchemicals for research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MOLEQLAR Comparables

Compare MOLEQLAR with similar companies based on industry and business-model similarity.

MOLEQLAR comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Purovitalis
88%
AVEA Life
85%
DoNotAge
85%

MOLEQLAR Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 9, 2023

Key People

Founding team and executive leadership

Clemens Klingler

Co-Founder And COO

Founding Team

Mario Gietl

Co-Founder & CMO

Founding Team

Max Griessinger

CEO & Founder

Founding Team

MOLEQLAR Investors

Notable investors and investment history

MOLEQLAR investors
InvestorRounds
Rheingau FoundersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 25, 156% of headcount.

  • Jun 15, 2026

    Open roles increased from 0 to 4, representing 25% of headcount.

MOLEQLAR Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MOLEQLAR Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MOLEQLAR's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerlin
Employee Range16
Year Founded2020
Last FundingNov 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?